80 related articles for article (PubMed ID: 7136001)
1. The fate of [14C]trithiozine in man.
Renwick AG; Pettet JL; Gruchy B; Corina DL
Xenobiotica; 1982 May; 12(5):329-43. PubMed ID: 7136001
[TBL] [Abstract][Full Text] [Related]
2. Disposition and metabolism of indeloxazine hydrochloride, a cerebral activator, in rats.
Kamimura H; Enjoji Y; Sasaki H; Kawai R; Kaniwa H; Niigata K; Kageyama S
Xenobiotica; 1987 Jun; 17(6):645-58. PubMed ID: 3630201
[TBL] [Abstract][Full Text] [Related]
3. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
Prakash C; Cui D
Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
[TBL] [Abstract][Full Text] [Related]
4. Biotransformation of trithiozine. III - Isolation and identification of further metabolites in rat urine.
Ventura P; Cornelli U; Pifferi G; Frigerio A
Farmaco Sci; 1977 Sep; 32(9):640-9. PubMed ID: 902759
[TBL] [Abstract][Full Text] [Related]
5. High-performance liquid chromatographic determination of trithiozine and its neutral metabolites in human plasma and urine.
Crolla T; Borsa M; Pifferi G
J Chromatogr; 1981 Feb; 222(2):257-63. PubMed ID: 7251743
[TBL] [Abstract][Full Text] [Related]
6. Metabolism and disposition of clarithromycin in man.
Ferrero JL; Bopp BA; Marsh KC; Quigley SC; Johnson MJ; Anderson DJ; Lamm JE; Tolman KG; Sanders SW; Cavanaugh JH
Drug Metab Dispos; 1990; 18(4):441-6. PubMed ID: 1976065
[TBL] [Abstract][Full Text] [Related]
7. Metabolism and kinetics of amlodipine in man.
Beresford AP; McGibney D; Humphrey MJ; Macrae PV; Stopher DA
Xenobiotica; 1988 Feb; 18(2):245-54. PubMed ID: 2967593
[TBL] [Abstract][Full Text] [Related]
8. Metabolism and excretion of a new anxiolytic drug candidate, CP-93, 393, in healthy male volunteers.
Prakash C; Cui D; Baxter JG; Bright GM; Miceli J; Wilner K
Drug Metab Dispos; 1998 May; 26(5):448-56. PubMed ID: 9571226
[TBL] [Abstract][Full Text] [Related]
9. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl] benzoic acid. 4th communication: absorption, metabolism, excretion and plasma protein binding in various animals and man.
Mizojiri K; Okabe H; Sugeno K; Misaki A; Ito M; Kominami G; Esumi Y; Takaichi M; Harada T; Seki H; Inaba A
Arzneimittelforschung; 1997 Mar; 47(3):259-69. PubMed ID: 9105544
[TBL] [Abstract][Full Text] [Related]
10. Absorption, metabolism, and excretion of [14C]imidafenacin, a new compound for treatment of overactive bladder, after oral administration to healthy male subjects.
Ohmori S; Miura M; Toriumi C; Satoh Y; Ooie T
Drug Metab Dispos; 2007 Sep; 35(9):1624-33. PubMed ID: 17567733
[TBL] [Abstract][Full Text] [Related]
11. Metabolism of labetalol by animals and man.
Martin LE; Hopkins R; Bland R
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):695-710. PubMed ID: 990152
[TBL] [Abstract][Full Text] [Related]
12. [Studies on the biotransformation of fominoben-HCl in man (author's transl)].
Zimmer A; Krüger G; Prox A; Stahl E; Wolter B; Wachsmuth H; Köster P
Arzneimittelforschung; 1978; 28(4):688-92. PubMed ID: 155457
[TBL] [Abstract][Full Text] [Related]
13. The disposition and metabolic fate of 14C-meropenem in man.
Harrison MP; Haworth SJ; Moss SR; Wilkinson DM; Featherstone A
Xenobiotica; 1993 Nov; 23(11):1311-23. PubMed ID: 8310714
[TBL] [Abstract][Full Text] [Related]
14. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs.
Huskey SE; Dean BJ; Doss GA; Wang Z; Hop CE; Anari R; Finke PE; Robichaud AJ; Zhang M; Wang B; Strauss JR; Cunningham PK; Feeney WP; Franklin RB; Baillie TA; Chiu SH
Drug Metab Dispos; 2004 Feb; 32(2):246-58. PubMed ID: 14744948
[TBL] [Abstract][Full Text] [Related]
15. Disposition and metabolism of finasteride in dogs.
Carlin JR; Christofalo P; Arison BH; Ellsworth RE; Rosegay A; Miller RR; Chiu SH; VandenHeuvel WJ
Drug Metab Dispos; 1997 Jan; 25(1):100-9. PubMed ID: 9010636
[TBL] [Abstract][Full Text] [Related]
16. The metabolic fate of 14C-ximoprofen in rats, baboons and humans.
Mayo BC; Chasseaud LF; Hawkins DR; Taylor IW; Legeai J
Xenobiotica; 1990 Mar; 20(3):233-46. PubMed ID: 2336835
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of the calcium antagonist gallopamil in man.
Weymann J; Bühler V; Hege HG; Müller-Peltzer H; Schenk G; Stieren B; Hollmann M
Arzneimittelforschung; 1989 May; 39(5):605-7. PubMed ID: 2757679
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of 14C-estazolam in dogs and humans.
Machinist JM; Bopp BA; Anderson DJ; Granneman GR; Sonders RC; Tolman K; Buchi K; Rollins D
Xenobiotica; 1986 Jan; 16(1):11-20. PubMed ID: 2868576
[TBL] [Abstract][Full Text] [Related]
19. The disposition of clavulanic acid in man.
Bolton GC; Allen GD; Davies BE; Filer CW; Jeffery DJ
Xenobiotica; 1986 Sep; 16(9):853-63. PubMed ID: 3765664
[TBL] [Abstract][Full Text] [Related]
20. Absorption, distribution, metabolism, and elimination of the direct renin inhibitor aliskiren in healthy volunteers.
Waldmeier F; Glaenzel U; Wirz B; Oberer L; Schmid D; Seiberling M; Valencia J; Riviere GJ; End P; Vaidyanathan S
Drug Metab Dispos; 2007 Aug; 35(8):1418-28. PubMed ID: 17510248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
